Pregnancy Outcomes After Transcervical Radiofrequency Ablation of Uterine Fibroids with the Sonata System

Christoffel, Ladina; Bends, Ralf; Toub, David; Schiermeier, Sven; Pschadka, Gregor; Engelhardt, Matthias; Quinn, Stephen; Hartmann, Michael; Habiba, Marwan; Felberbaum, R.; Brössner, Anke; Schippert, Cordula; Römer, Thomas

doi:10.1089/gyn.2021.0136

Cited by 15 publications

(7 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…31 Similarly, in a case series of 28 women after transcervical RFA, there were 36 pregnancies resulting in 20 full-term deliveries (the majority [60%] were cesarean), three therapeutic abortions, and eight spontaneous abortions, with no significant morbidities. 32 Observed rates of spontaneous abortion (12%) are similar to those in the general population, and approximately half of women were able to safely undergo vaginal delivery. 30 No events of placenta accreta spectrum or uterine rupture have been reported; however, these are rare events, and further study is needed to assess these theoretical risks.…”

Section: Fertilitymentioning

confidence: 70%

Radiofrequency Ablation of Leiomyomas

Stewart

Greenberg

Kho

et al. 2023

Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

show abstract

Section: Fertilitymentioning

confidence: 70%

Radiofrequency Ablation of Leiomyomas

Stewart

Greenberg

Kho

et al. 2023

Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

show abstract

“…Postablation MRI has shown no reduction in uterine wall thickness or development of myometrial scar. 40 This is an important finding as vaginal delivery may be contraindicated in some patients who undergo laparoscopic or abdominal myomectomy due to risk of uterine dehiscence and rupture. Likewise, postmyomectomy intrauterine adhesion formation can be as prevalent as 45%, but synechiae have not been seen after RFA during hysteroscopic evaluation.…”

Section: Fertility Outcomesmentioning

confidence: 99%

Updates on the Surgical Approach to Fibroids: The Importance of Radiofrequency Ablation

Kwon,

Abu-Alnadi

2023

Semin intervent Radiol

View full text Add to dashboard Cite

Uterine fibroids are the most common benign neoplasm of the female pelvis and have a lifetime prevalence exceeding 80% among African American women and approaching 70% among Caucasian women. Approximately 50% of women with fibroids experience symptoms which can range from heavy menstrual bleeding and bulk-related symptoms such as pelvic pressure with bladder and bowel dysfunction to reproductive dysfunction (e.g., infertility or obstetric complications) and pain. The choice of treatment is primarily guided by the type of symptoms in the individual patient and whether they prefer to retain fertility. While hysterectomy provides definitive resolution of fibroid symptoms and remains the most common treatment option, this procedure is invasive with a long recovery window. Radiofrequency ablation (RFA) is now emerging as a uterine preserving and minimally invasive therapy for symptomatic fibroids. Since its introduction, growing evidence for safety and efficacy of RFA has been generated with low rates of complications. This review will discuss RFA for the management of symptomatic uterine fibroids with a special focus on technical approaches, short- and long-term outcomes including fertility outcomes.

show abstract

“…To prevent misdiagnosis or treatment of an unexpected sarcoma, the number, size and type of fibroids should be clearly evaluated using ultrasound and magnetic resonance imaging. Experts have recommended that it is possible to schedule a pregnancy within 3 months of the TRFA after a follow-up ultrasound has been performed [30]. It is noteworthy that no prospective controlled trials have been performed on patients willing to have children.…”

Section: Transcervical Ultrasound-guided Radiofrequency Ablation (Trfa)mentioning

confidence: 99%

Conservative surgical treatment of uterine fibroids in women of childbearing age

2023

European Journal of Gynaecological Oncology

View full text Add to dashboard Cite

Uterine fibroids are benign gynecologic tumors, and women aged between 30 to 50 years are known to have a high incidence of uterine fibroids. A growing number of pharmacotherapies and minimally invasive organ-preserving treatments have been designed and conducted over the past few years. However, there has not been any therapeutic drugs exhibiting an ideal therapeutic effect and low recurrence rate, such that the surgical treatment continues to be primarily employed in the actual clinical treatment. In general, surgical treatment has been performed as the organ- and fertility-preserving hysteroscopic or laparoscopic resections of the fibroids. Minimally invasive surgical equipment (e.g., hysteroscopy, traditional porous laparoscopy, trans-umbilical laparoscopy, transvaginal laparoscopy, as well as robot-assisted laparoscopy) has been extensively applied to clinical treatment. Compared with traditional laparotomy, minimally invasive surgical equipment is characterized by minimally invasive surgery, high efficiency and safety. As medical technology has been leaping forward, interventional therapy and radiofrequency ablation can also be employed for treating uterine fibroids. In accordance with the research progress worldwide, the current situation, limitations, and advantages of the treatment of uterine fibroids in patients with fertility requirements are reviewed in this study.

show abstract

Pregnancy Outcomes After Transcervical Radiofrequency Ablation of Uterine Fibroids with the Sonata System

Cited by 15 publications

References 41 publications

Radiofrequency Ablation of Leiomyomas

Radiofrequency Ablation of Leiomyomas

Updates on the Surgical Approach to Fibroids: The Importance of Radiofrequency Ablation

Conservative surgical treatment of uterine fibroids in women of childbearing age

Contact Info

Product

Resources

About